KVUE Stock Chart & Stats
$329.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$259.01 - $500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)79.00
Market Cap
$647.23B
Enterprise Value$41.40K
Total Cash (Recent Filing)$1.07B
Total Debt (Recent Filing)$8.66B
Price to Earnings (P/E)22.7
Beta-0.15
Next Earnings
Aug 06, 2026EPS Estimate
5.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.85
Shares Outstanding1,920,008,700
10 Day Avg. Volume29
30 Day Avg. Volume79
Financial Highlights & Ratios
PEG Ratio0.52
Price to Book (P/B)3.06
Price to Sales (P/S)2.18
P/FCF Ratio19.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$337.22Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $259.01 and its highest was $500.00 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $647.23B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 12 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on May 07, 2026. The company reported $5.603 earnings per share for the quarter, beating the consensus estimate of $4.587 by $1.016.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. does not currently pay dividends.
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 5.59.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,920,008,700 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $5.603 in its last earnings report, beating expectations of $4.587. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in MX:KVUE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kenvue, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$337.22 (― Downside)
$337.22 (― Downside)
Blogger Sentiment
Bullish
MX:KVUE Sentiment 70%
Sector Average 62%
Sector Average 62%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.25%
12-Months-Change
Fundamentals
Return on Equity
4.45%
Trailing 12-Months
Asset Growth
2.27%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
KVUE Revenue Breakdown
42.17% Self Care
27.20% Skin Health and Beauty
30.63% Essential Health

KVUE Stock 12 Month Forecast
Average Price Target
$337.22